PubMed:32178765 / 1527-1696 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":169},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"The primary endpoint was American College of Rheumatology 20% improvement (ACR20) at week 24 in all patients per assigned treatment group using non-responder imputation."}